Concepedia

William F. Pierce

WF

24

Publications

2.2K

Citations

22

H-Index

2012

Active since

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Center for Devices and Radiological Health

United States Department of Health and Human Services

William F. Pierce is an author at Center for Drug Evaluation and Research specializing in pharmacotherapy, cancer therapeutics, and cancer research.

Top concepts

MedicineOncologyCancer TherapyCancer ResearchClinical TrialsPharmacotherapyHealthUrologyPharmacologyRadiation Oncology

Publications per year

2012–2024

24

Publications

24

FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer

Jaleh Fallah, Sundeep Agrawal, Haley Gittleman et al. · Clinical Cancer Research · 2022 · 200 citations · Full text

Urology, Dry Mouth, Genitourinary Cancer +14

FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma

Sandra J. Casak, Martha Donoghue, Lola A. Fashoyin‐Aje et al. · Clinical Cancer Research · 2020 · 170 citations

FDA Approval Summary: Pembrolizumab for the First-line Treatment of Patients with MSI-H/dMMR Advanced Unresectable or Metastatic Colorectal Carcinoma

Sandra J. Casak, Leigh Marcus, Lola A. Fashoyin‐Aje et al. · Clinical Cancer Research · 2021 · 167 citations · Full text

Radium Ra 223 Dichloride Injection: U.S. Food and Drug Administration Drug Approval Summary

Paul G. Kluetz, William F. Pierce, V. Ellen Maher et al. · Clinical Cancer Research · 2013 · 162 citations

Dichloride Injection, Cancer Management, Pharmacotherapy +17

FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious <i>BRCA</i> Mutation–Associated Advanced Ovarian Cancer

Sanjeeve Balasubramaniam, Julia A. Beaver, Sara Horton et al. · Clinical Cancer Research · 2017 · 158 citations

Rows per page

1–5 of 24